Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Clinical trial NCT07265947 · RECRUITING
Trial details
- NCT number
- NCT07265947
- Sponsor
- Tyra Biosciences, Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2030-10-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.